Related Experiment Video
Updated: Apr 28, 2026
Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety
Published on: November 11, 2022
The importance of serotonin and noradrenaline in anxiety
Pierre Blier1, Mostafa El Mansari
1Institute of Mental Health Research, University of Ottawa, Ottawa, Canada.
Abstract:
The therapeutics of obsessive-compulsive disorder (OCD) involves the serotonergic system in the brain; the selective serotonin reuptake inhibitors (SSRIs) are the only class of drugs to be consistently effective for this disorder. Preclinical studies in the orbito-frontal cortex - a brain area known to be involved in mediation of OCD symptoms - show that sustained administration of SSRI for 2 months leads to enhanced 5-HT release. Initially, raised 5-HT levels, resulting from serotonin (5-HT) reuptake inhibition, over-activates the cell body 5-HT1A autoreceptor, which has an inhibitory effect on the neuronal firing rate. However, after long-term administration of SSRIs, these 5-HT1A autoreceptors become desensitized to the raised extracellular 5-HT levels, and increase 5-HT transmission. The recovery of neuronal firing rate is faster with escitalopram (the active S-enantiomer of citalopram) than with citalopram, which may be due to different mechanisms of action. The 5-HT system has reciprocal interactions with the noradrenaline (NA) system. Although not a major mediator in the treatment of OCD symptomatology, patients with anxiety disorders such as panic disorder have increased NA reactivity and/or tone. Long-term SSRI administration reduces the firing rate of NA neurones, unlike 5-HT neurones. Evidence indicates that accrued 5-HT levels have an inhibitory modulatory effect on NA transmission, thus indicating the clinical relevance of SSRI treatment for anxiety disorders. The different effectiveness of the SSRIs escitalopram and citalopram in enhancing synaptic 5-HT levels may be due to the inhibitory action of the R-enantiomer in racemic citalopram on S-enantiomer binding to the 5-HT transporter. This allows escitalopram to produce higher extracellular 5-HT levels than can be achieved by the equivalent S-enantiomer dose of citalopram. Escitalopram is therefore a viable front-line treatment option for people with anxiety disorders, and possibly for those who have failed to respond to conventional SSRI therapies.
Insights
Selective serotonin reuptake inhibitors (SSRIs) enhance serotonin (5-HT) transmission in the brain, crucial for treating obsessive-compulsive disorder (OCD). Escitalopram demonstrates faster neuronal recovery than citalopram, suggesting superior efficacy for anxiety disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are the primary pharmacotherapy for obsessive-compulsive disorder (OCD), targeting the brain's serotonergic system.
- Preclinical studies indicate that sustained SSRI administration enhances serotonin (5-HT) release in the orbito-frontal cortex, a region implicated in OCD.
- Initial SSRI treatment leads to 5-HT1A autoreceptor over-activation, but long-term use results in autoreceptor desensitization and increased 5-HT transmission.
Purpose of the Study:
- To investigate the differential effects of escitalopram and citalopram on 5-HT transmission and neuronal firing rates.
- To explore the interaction between the serotonergic and noradrenergic systems in the context of SSRI treatment for anxiety disorders.
- To evaluate the potential of escitalopram as a front-line treatment for anxiety disorders and for patients refractory to other SSRIs.
Main Methods:
- Preclinical studies examining the effects of sustained SSRI administration on 5-HT release and 5-HT1A autoreceptor function in the orbito-frontal cortex.
- Comparative analysis of neuronal firing rate recovery with escitalopram versus citalopram.
- Investigation of the modulatory effects of 5-HT on noradrenaline (NA) neurone activity.
Main Results:
- Long-term SSRI administration desensitizes 5-HT1A autoreceptors, leading to increased 5-HT transmission.
- Escitalopram promotes a faster recovery of neuronal firing rate compared to citalopram, potentially due to its enantiomeric composition.
- SSRIs reduce noradrenaline (NA) neurone firing rates, suggesting a mechanism for their efficacy in anxiety disorders.
Conclusions:
- Escitalopram's distinct mechanism, possibly related to the R-enantiomer in racemic citalopram, allows for higher extracellular 5-HT levels, enhancing its therapeutic potential.
- The inhibitory modulation of NA transmission by elevated 5-HT levels underscores the clinical relevance of SSRIs for anxiety disorders.
- Escitalopram is a promising first-line treatment option for anxiety disorders and may benefit patients with inadequate responses to other SSRIs.
Related Concept Videos
01:26Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
01:31Neurotransmitters
01:30Neurotransmitters
01:18Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone